AstraZeneca Shows Off New Farxiga Data for Diabetes Patients with Chronic Kidney Disease
AstraZeneca’s drug Farxiga could receive a new indication for a subset of diabetes patients based on Phase III data that was released today.
Source: BioSpace
AstraZeneca’s drug Farxiga could receive a new indication for a subset of diabetes patients based on Phase III data that was released today.
Source: BioSpace